Status:
UNKNOWN
Cranial Electrotherapy Stimulation on Anesthetics Consumption and Postoperative Pain
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Opioid Use
Cytokine
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Cranial electrotherapy stimulation (CES) is a non-invasive intervention to treat anxiety, depression, insomnia, and pain. But clinical studies and applications of CES in relation to acute postoperativ...
Detailed Description
Cranial electrotherapy stimulation (CES) is a non-invasive and safe intervention, transmitting microcurrents of brain stimulation and releasing various neurotransmitters such as endorphin and downstre...
Eligibility Criteria
Inclusion
- Patients undergoing colon cancer surgery
Exclusion
- presence of an implantable device (e.g., pacemaker)
- pregnancy
- having a known mental illness (e.g., schizophrenia, mood disorder, bipolar disorder, etc.
- cancer of the head and neck or brain tumor or brain metastasis
- having delirium
Key Trial Info
Start Date :
January 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03825471
Start Date
January 14 2019
End Date
December 31 2020
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TriService General Hospital
Taipei, Taiwan, 11490